Charles F Harney - Net Worth and Insider Trading

Charles F Harney Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles F Harney owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .

Click here to see the complete history of Charles F Harney’s form 4 insider trades.

Insider Ownership Summary of Charles F Harney

Ticker	Comapny	Transaction Date	Type of Owner
GALT	Galectin Therapeutics Inc	2003-12-12	Chief Financial Officer

Charles F Harney Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Charles F Harney Ownership Network

Ownership Network List of Charles F Harney

No Data

Ownership Network Relation of Charles F Harney

Charles F Harney Owned Company Details

What does Galectin Therapeutics Inc do?

Who are the key executives at Galectin Therapeutics Inc?

Charles F Harney is the Chief Financial Officer of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .

Galectin Therapeutics Inc (GALT) Insider Trades Summary

Over the past 18 months, Charles F Harney made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 16,300 shares made by Kevin D Freeman , and a net purchase of 4,500 shares made by Zordani Richard A. Jr. .

In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 15,300 shares, with a net purchase of 15,300 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.

Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Galectin Therapeutics Inc Insider Transactions

No Available Data

Charles F Harney Mailing Address

Above is the net worth, insider trading, and ownership report for Charles F Harney. You might contact Charles F Harney via mailing address: C/o Pro Pharmaceuticals Inc, 189 Wells Ave, Newton Ma 02459.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.